URGO Medical

What URGO Medical does

URGO GmbH, operating under the URGO Medical brand, is a German medical device company specializing in advanced wound care and compression therapy, headquartered in Sulzbach (Saarland) and operating primarily in Germany and Austria. Founded in 2001 as the German subsidiary of the French parent Laboratoires URGO S.A.S, the company is celebrating its 25th anniversary in 2026 and employs between 101 and 250 staff under managing directors Judith Stahlhut and Xavier Camps.

The company's product portfolio is built on a proprietary wound-healing matrix platform called TLC (Lipidocolloid Technology / TLC-Wundheilungsmatrix), with three patented variants: base TLC for moist wound environment and atraumatic dressing change, TLC-NOSF (Sucrose-Octasulfat) for accelerated chronic-wound healing, and TLC-Ag (silver salt) for antimicrobial action. The portfolio spans wound cleansing (UrgoClean), advanced healing (UrgoStart Plus / UrgoStart Plus Absorb), contact dressings (UrgoTül and its foam/silver sub-lines), superabsorbent dressings (UrgoSuperabsorber, UrgoSuperSuperabsorber), and compression therapy (UrgoK1, UrgoK2). Clinical evidence spans randomized controlled trials (EXPLORER, CHALLENGE), large prospective observational studies (1,140 and 1,558 patients), and more than 54,000 patients across the TLC platform.

URGO Medical generates revenue through one-time sales of its medical devices via a dual distribution model: a direct field sales force covering hospitals, practices, and wound care centers, combined with a B2B e-commerce storefront (shop.urgo.de, powered by Shopware) and pharmacy distribution for pharmacy-only SKUs. Customer segments are doctors, nurses, and wound care specialists on the professional side, with secondary patient and pharmacy channels. The company supports demand generation through ICW-certified continuing education, the annual Drei-Länder-Wundpreis award across Germany, Austria, and Switzerland, and partnerships including the Healico digital wound documentation app. Pricing is not publicly disclosed; the B2B shop applies a EUR 120 minimum order with an EUR 10 (Germany) / EUR 20 (Austria) handling fee below threshold.

Name

URGO Medical

Legal name

URGO GmbH

Website

https://urgo.de

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Short description

URGO Medical (URGO GmbH) is a German medical device subsidiary of Laboratoires URGO S.A.S that develops and sells advanced wound care dressings and compression therapy products based on its proprietary TLC (Lipidocolloid) matrix platform, serving healthcare professionals, hospitals, and pharmacies across Germany and Austria.

Ownership category

akta.pro rank

Product category

Advanced Wound Care Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film) (HLAHALAA)

akta.pro secondary industries

Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments) (HLAHALAF), Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps) (HLAHAMAH), Wound Care & Diabetic Foot Infection (HLAKAGAK)

Keywords

• Advanced wound care
• Compression therapy
• Medical wound dressings
• Chronic wound management
• Medical devices manufacturing

Headquarters

HQ city

Sulzbach

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Medical Device and Wound Care Product Sales: URGO Medical generates revenue through the sale of proprietary wound care dressings, compression therapy products, and superabsorbent wound pads. Products are sold directly to healthcare professionals (doctors, nurses, wound care specialists) via a B2B e-commerce platform and through field sales representatives. Pharmacy sales are also supported for over-the-counter apothecary products.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Core offering

URGO GmbH manufactures and sells advanced wound care dressings and compression therapy systems for healthcare professionals, hospitals, clinics, and pharmacies. Its portfolio centers on the proprietary TLC (Lipidocolloid) wound healing matrix family — including TLC base, TLC-NOSF (Sucrose-Octasulfat), and TLC-Ag (Silver) — alongside superabsorbent dressings (UrgoSuperabsorber, UrgoSuperSuperabsorber), wound cleansing products (UrgoClean), and multi-layer compression bandages (UrgoK1).

Product overview

URGO Medical offers a comprehensive portfolio of advanced wound care products and compression therapy solutions. The core product lines include: UrgoClean (wound cleaning dressings with polyabsorbent fibers), UrgoStart Plus family (TLC-NOSF wound dressings with Sucrose-Octasulfate technology for accelerated healing), UrgoTül family (lipidocolloid wound contact dressings), superabsorbent dressings (UrgoSuperabsorber and UrgoSuperSuperabsorber), and UrgoK1 compression bandage. Products are primarily distributed through medical professionals (clinics, practices, pharmacies) via their web shop. The company celebrated 25 years of operations in 2026, with their TLC (Lipidocolloid Technology) matrix being a foundational innovation spanning multiple product lines.

Differentiator

Problem solved

Functional benefit

Brands

• UrgoClean: Wound dressing with continuous cleaning effect for infection control
• UrgoStart Plus
• UrgoK1
• UrgoTül
• UrgoSuperabsorber
• UrgoSuperSuperabsorber
• UrgoTül Foam
• UrgoTül Foam Border
• UrgoTül Ag/Silver

Products and services

• UrgoClean Border Wound dressing with cleaning fibers (polyabsorbent cleansing fibers) for continuous wound debridement and infection control, featuring the 'Saubertrick' mechanism for effective exudate management. For healthcare professionals managing chronic wounds.
• UrgoClean Kompresse Wound dressing with cleaning fibers that continuously removes bacteria, wound debris, and biofilm from the wound, facilitating infection control. Part of the UrgoClean family for chronic wound management.
• UrgoK1 Single-component multi-layer compression bandage combining short-stretch and long-stretch bandage properties in one bandage, providing 24-hour effective compression with maximum wearing comfort, independently of patient mobility. Used for venous leg ulcers and lymphatic conditions.
• UrgoStart Plus Absorb Highly absorbent wound dressing combining TLC-NOSF matrix (Sucrose-Octasulfate) with cleaning fibers and superabsorbent core. Promotes accelerated wound healing and enables continuous cleaning and exudate management for chronic wounds.
• UrgoTül Flexible wound contact dressing with patented TLC (Lipidocolloid Technology) matrix. Used for acute and chronic wounds in granulation and epithelialization phases, including epidermolysis bullosa, pressure ulcers, and burns.
• UrgoSuperSuperabsorber Sterile superabsorbent wound dressing for exuding wounds with a superabsorbent core that absorbs and retains exudate vertically from the wound contact layer, forming a gel to minimize maceration risk. Features a blue hydrophobic backing to minimize moisture leakage.
• UrgoSuperabsorber Superabsorbent wound dressing for heavily exuding wounds with a high-capacity absorbent core. Provides effective exudate management even under compression therapy.
• UrgoTül Foam Absorbent foam wound dressing with microadhesive TLC matrix. Combines foam absorption properties with lipidocolloid technology for wound healing support.
• UrgoTül Foam Border Highly absorbent foam dressing with adhesive border. Features TLC matrix technology for atraumatic dressing changes.
• UrgoTül Ag/Silver Antimicrobial flexible wound contact dressing with TLC-Ag (silver salt) wound healing matrix. Provides antimicrobial action against pathogens for wounds with signs of local infection.
• UrgoStart Plus Border Highly absorbent wound dressing with silicone adhesive border. Combines TLC-NOSF matrix, cleaning fibers, and superabsorbent core for wound healing and continuous cleaning.
• UrgoStart Plus Kompresse Absorbent wound dressing with TLC-NOSF matrix and cleaning fibers. Can be cut to size and combined with secondary dressings.

Quantifiable outcome

• Urgo K2 compression bandage achieved over 50% reduction in ulcer area in a prospective, observational, multicenter study across six districts in Andalusia, Spain, compared to lower-performing alternatives with comparable pressures.
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• ShopwarecoreTechnology or IntegrationURGO Medical's e-commerce platform (shop.urgo.de) is powered by Shopware, a German e-commerce CMS. Shopware serves as the technical infrastructure for the B2B online shop, handling product catalog, customer accounts, ordering, and order processing. A data processing agreement (AVV) has been established per GDPR requirements.
• URGO FoundationcoreStrategic or Co-development PartnerThe URGO Foundation (Foundation Urgo) organizes the annual Drei-Länder-Wundpreis (Three-Country Wound Prize), a prestigious award in wound care across Germany, Austria, and Switzerland. URGO Medical is associated with this foundation for educational initiatives and knowledge transfer in wound care.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Solventum (formerly 3M Health Care): Spun off from 3M, Solventum's Health Care segment includes advanced wound care products (Tegaderm, V.A.C. therapy). Comparable as a broad incumbent with overlapping wound care offerings across hospitals and home care.
• Essity (BSN medical): Swedish hygiene and health company that acquired BSN medical, gaining a wound care and compression portfolio (Cutimed, JOBST). Competes in advanced wound care and compression therapy across European markets.

Emerging players

• Organogenesis: US regenerative medicine company specializing in advanced wound care biologics and skin substitutes (Apligraf, Dermagraft). Represents the high-end biologic/regenerative segment that competes with URGO's TLC-NOSF in chronic wound management.

Direct peers

• Mölnlycke Health Care: Swedish global leader in advanced wound care (Mepilex, Mepitel, Avance) and surgical solutions. Directly comparable as a medical device company focused on advanced wound dressings with strong clinical evidence and HCP-focused GTM.
• Smith+Nephew: Global medical device company with a substantial Advanced Wound Management division (Allevyn, Acticoat, PICO). Competes head-to-head with URGO Medical in hospital and community wound care across Europe.
• ConvaTec: UK-listed medical device company with a leading Advanced Wound Care portfolio (Aquacel, DuoDERM, FoamLite). Directly comparable as a wound care-focused business competing for the same HCP and formulary budgets.
• Coloplast: Danish multinational with a dedicated Wound & Skin Care division (Biatain, Aquacel). Closely comparable business model focused on advanced wound dressings distributed through HCPs and home care channels in DACH and globally.
• Lohmann & Rauscher: German-Austrian family-owned medical device company specializing in wound care and compression therapy. Direct overlap with URGO Medical in DE/AT markets, particularly in compression bandages and chronic wound dressings.
• PAUL HARTMANN: German-headquartered medical device company with a strong Wound Management division (Hydrocoll, Cosmopor). A direct competitor in the German home and hospital wound care market with established DACH distribution.

Regional players

• Medi (medi GmbH & Co. KG): German family-owned medical device company with a strong compression therapy and wound care portfolio (mediven, circaid). Direct overlap with URGO Medical in German compression therapy and wound care channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@urgogmbh
• Facebookfacebook.com/urgo.de
• LinkedInlinkedin.com/company/urgo-gmbh
• Instagraminstagram.com/urgo_gmbh
• Xx.com/urgogmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about URGO Medical